Pulmonology

ReCode Therapeutics Appoints John G. Matthews, MBBS, MRCP, Ph.D., as Senior Vice President, Clinical Development

Retrieved on: 
Monday, April 17, 2023
Health, Genetics, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, 23andMe, GSK plc, Royal Brompton Hospital, Asthma, Drug development, MBBS, Therapy, SORT, Doctor of Philosophy, Bias, MBA, Recode, Inflammation, Messenger, Pulmonology, Novartis, Lane, Patient, Respiratory disease, Cystic fibrosis, Hospital, LNP, Biomarker, Pharmacology, Imperial College London, MRCP, Disease, Medical device, Pharmaceutical industry, Genentech

ReCode Therapeutics , a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of John G. Matthews, MBBS, MRCP, Ph.D., as senior vice president of clinical development.

Key Points: 
  • ReCode Therapeutics , a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of John G. Matthews, MBBS, MRCP, Ph.D., as senior vice president of clinical development.
  • Dr. Matthews will oversee clinical development planning and strategy.
  • “We are delighted to welcome Dr. Matthews to build and lead our clinical team,” said Shehnaaz Suliman, M.D., MBA, M.Phil., chief executive officer, ReCode Therapeutics.
  • He spent the previous ten years at Genentech, a subsidiary of Roche, in leadership roles including senior group medical director.

Evolution Research Group, LLC Further Expands Early Phase Capabilities at Clinical Pharmacology of Miami (CPMI) with Increased Medical Team Expertise

Retrieved on: 
Wednesday, April 12, 2023
Clinical pharmacology, Obesity, University, ERG, Diabetes, Internal medicine, SLT, Kidney disease, Public, Obstetrics and gynaecology, Clinical trial, NDA, DRS, Pharmacy, Liver, Pulmonology, Neuroscience, Pharmacist, Pain management, Medical director, MD, CPMI, Gynaecology, CSF, Growth, Principal, Safety, Organon, Pharmaceutical industry, Obstetrics, Anesthesiology, Bayer, Medicine

The expansion of the medical team has enabled CPMI to offer additional capabilities such as CSF sampling, which is currently in high demand.

Key Points: 
  • The expansion of the medical team has enabled CPMI to offer additional capabilities such as CSF sampling, which is currently in high demand.
  • Dr. Prezioso then accepted a role as Medical Director and Principal Investigator with a phase 1 unit in the northeast before relocating to Florida.
  • "I am thrilled to have joined the team at CPMI and am amazed by the growth they have experienced under the ownership of ERG.
  • Dr. Fernandez received his medical degree at the University of Miami, Miller School of Medicine, where he also did his residency training.

CHOC earns national recognition for excellence in respiratory care

Retrieved on: 
Wednesday, March 22, 2023
Gold Seal, TJC, Joint Commission, AARC, RRT, Orange County, Multimedia, Certification, American Association for Respiratory Care, JTC, Children's Hospital of Orange County, Hospital, Patient, Gold, Patient safety, Master of Science, RN, COE, Knowledge, APEX, Health, MHA, CHOC, Nursing, Pulmonology

ORANGE, Calif., March 22, 2023 /PRNewswire/ -- Children's Hospital of Orange County ( CHOC ) was recently honored with two national accolades for excellence in respiratory care.

Key Points: 
  • ORANGE, Calif., March 22, 2023 /PRNewswire/ -- Children's Hospital of Orange County ( CHOC ) was recently honored with two national accolades for excellence in respiratory care.
  • It is the only children's hospital on the West Coast—and just one of five in the nation—to receive the 2023 – 2024 American Association for Respiratory Care (AARC) Apex Recognition Award.
  • "I am very proud of our respiratory care team for their unwavering commitment to the highest standards of safe, quality care.
  • Respiratory care departments must demonstrate their commitment to excellence in professional development, evidence-based care, patient safety, and quality improvement.

BELLUS Health Reports Year 2022 Financial Results and Business Highlights

Retrieved on: 
Tuesday, March 21, 2023
Health, Other Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, Workforce, CALM, RCC, Clinical trial, Otorhinolaryngology, Pharmacokinetics, American Academy, Gastroenterology, G&A, Pulmonology, Research, William Frankland (allergist), Development, US, Patient, Investment, Physician, Administration, Annual general meeting, TSX, BLU, Poster, FDA, Society, P2X3, Pharmaceutical industry, Nursing, Cryptocurrency, In silico clinical trials

The CALM Phase 3 clinical program was initiated in the fourth quarter of 2022, with patient enrollment ongoing.

Key Points: 
  • The CALM Phase 3 clinical program was initiated in the fourth quarter of 2022, with patient enrollment ongoing.
  • BELLUS Health conducted validation work on the VitaloJAK cough monitoring system comparing compressed vs. non-compressed recordings in a cohort of 45 SOOTHE Phase 2b trial participants.
  • BELLUS Health submitted a validation protocol and statistical analysis plan to the FDA in the fourth quarter of 2022.
  • Topline results from CALM-1 are expected in the second half of 2024, and topline results from CALM-2 in 2025.

Yashoda Hospitals First in India and Asia to Perform Diagnostic Bronchoscopy with LungVision AI-Driven Intraoperative CT Imaging

Retrieved on: 
Tuesday, March 21, 2023
CT, Partnership, Workflow, Hospital, Lung cancer, Pulmonology, Lung, Yashoda Hospitals, Patient, Artificial intelligence, Diagnosis, Biopsy, Medical imaging

CAMPBELL, Calif., March 21, 2023 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative CT imaging, announced that the interventional pulmonology team at Yashoda Hospitals in Hyderabad, India performed their first diagnostic bronchoscopy procedure using the LungVision™ system for navigation and intraoperative imaging and, in so doing, became the first in both India and Asia to offer LungVision™ advanced imaging to their patients.

Key Points: 
  • CAMPBELL, Calif., March 21, 2023 /PRNewswire/ -- Body Vision Medical, a leader in AI-driven, intraoperative CT imaging, announced that the interventional pulmonology team at Yashoda Hospitals in Hyderabad, India performed their first diagnostic bronchoscopy procedure using the LungVision™ system for navigation and intraoperative imaging and, in so doing, became the first in both India and Asia to offer LungVision™ advanced imaging to their patients.
  • "Lung Vision™ is the most convenient imaging platform for early diagnosis of lung nodules," says Dr. Hari Kishan Gonuguntla, Pulmonologist at Yashoda Hospitals in Hyderabad, India.
  • "The easy workflow and short learning curve reduces procedure time, making it my imaging modality of choice for peripheral lung nodule diagnosis."
  • Body Vision Medical's LungVision™ System uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative CT scans.

Olympus Webinar Highlights Differences in Single-Use and Reusable Bronchoscope Performance

Retrieved on: 
Tuesday, March 21, 2023
Suction, Perception, Bronchoscopic lung volume reduction, Olympus, UC San Diego Health, Pulmonology, Research, Doctor of Philosophy, MD, Physician, Health, Safety, Medical device, Medical imaging, Respiratory therapist

CENTER VALLEY, Pa., March 21, 2023 /PRNewswire/ -- Olympus today announced it is hosting a webinar led by interventional pulmonologist George Cheng, MD, PhD, from UC San Diego Health, who will review the full results from his study comparing the performance of reusable bronchoscopes to that of single-use bronchoscopes.

Key Points: 
  • CENTER VALLEY, Pa., March 21, 2023 /PRNewswire/ -- Olympus today announced it is hosting a webinar led by interventional pulmonologist George Cheng, MD, PhD, from UC San Diego Health, who will review the full results from his study comparing the performance of reusable bronchoscopes to that of single-use bronchoscopes.
  • With this data, physicians can make the most informed choice for diagnoses and treatment based on the patient, procedure, and site of care.
  • The most recent survey-based single-center study led by Dr. Cheng gathered information on the perception of bronchoscope performance from nine pulmonologists across categories that included maneuverability, suction capability, and imaging processing.
  • Additional studies are required to evaluate the practicality, safety, and cost efficiency of the H-SteriScope bronchoscope in clinical practice.

Body Vision Medical Expands Global Presence with Four New Distribution Agreements in Q1

Retrieved on: 
Wednesday, March 15, 2023
Lung cancer, Survival, Prevalence, Partnership, CT, Pulmonology, Patient, Artificial intelligence, Lung, Medical imaging

CAMPBELL, Calif., March 15, 2023 /PRNewswire/ -- In the first quarter of 2023, Body Vision Medical, a leader in AI-driven, intraoperative imaging signed exclusive distribution agreements with SumTage Enterprise Co., Ltd., Scanmed Technology Pte Ltd, ElsMor Medical System Ltd. and Supri Artigos Médicos Hospitalares Ltd. for distribution of its LungVision™ real-time, intraoperative CT imaging platform in Taiwan, Singapore, Israel and Brazil, respectively.

Key Points: 
  • Body Vision Medical signs exclusive distribution agreements in Taiwan, Singapore, Israel and Brazil.
  • CAMPBELL, Calif., March 15, 2023 /PRNewswire/ -- In the first quarter of 2023, Body Vision Medical, a leader in AI-driven, intraoperative imaging signed exclusive distribution agreements with SumTage Enterprise Co., Ltd., Scanmed Technology Pte Ltd, ElsMor Medical System Ltd. and Supri Artigos Médicos Hospitalares Ltd. for distribution of its LungVision™ real-time, intraoperative CT imaging platform in Taiwan, Singapore, Israel and Brazil, respectively.
  • Body Vision Medical's LungVision™ System uses artificial intelligence (AI) to transform X-ray images from any C-arm into real-time, intraoperative CT scans.
  • These distributor partnership signings support Body Vision Medical's growth strategy aimed at bringing the benefits of LungVision™ to pulmonologists and lung patients in 60 new markets over the next three years.

The Galaxy System™ by Noah Medical Receives FDA Clearance for Robotic Navigated Bronchoscopy

Retrieved on: 
Thursday, March 2, 2023
Doctor of Philosophy, FDA, Pulmonology, Biopsy, Lung, Risk, SAN, Lung cancer, Fluoroscopy, Galaxy, Medical imaging

SAN CARLOS, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced FDA clearance of the Galaxy System™.

Key Points: 
  • SAN CARLOS, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced FDA clearance of the Galaxy System™.
  • The Galaxy System and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures.
  • With this FDA clearance, we are excited to move into the commercial phase of our journey.”
    The Galaxy System features TiLT+ Technology™ with integrated tomosynthesis and augmented fluoroscopy.
  • The Galaxy System is the only robotic navigated bronchoscopy system on the market with a single-use, disposable bronchoscope, intentionally designed to improve efficiency and workflow plus potentially reduce the risk of cross-contamination.

Highmark Health, Allegheny Health Network Unveil North Fayette Health + Wellness Pavilion

Retrieved on: 
Wednesday, March 1, 2023
Sentinel, Neurosurgery, Infertility, Cardiology, Endocrinology, Doctor of Philosophy, Allegheny Health Network, IVF, Artificial insemination, Elective surgery, X-ray, Mammography, Anatomy, Reproductive medicine, Drive, Rheumatology, Life, New Home, Pavilion, Express, Gastroenterology, Patient, Google Images, Neurology, AHN, DEXA, Obstetrics, Site, Pulmonology, Bariatrics, Mental health, Woman, NORTH, Health, Hospital, Nursing, Medical imaging, Podiatry, MD

NORTH FAYETTE, Pa., March 1, 2023 /PRNewswire-PRWeb/ -- Representatives of Highmark Health and Allegheny Health Network (AHN) today joined community leaders for a ceremonial ribbon-cutting to celebrate the launch of AHN's North Fayette Health + Wellness Pavilion – a state-of-the-art facility offering an array of primary and specialty outpatient services anchored by the network's Center for Reproductive Medicine.

Key Points: 
  • "Today marks the latest milestone for AHN and Highmark Health in our ongoing journey to transform health care for patients and their families in the communities where they live and work," said Bruce Meyer, MD, Executive Vice President and Western PA Market President, Highmark Health.
  • AHN North Fayette will house one of the area's first 3T MRI scanners – a leading-edge technology that produces exceptionally detailed images of the anatomy.
  • AHN partnered with Orangestar Property Advisors and Sentinel Construction to develop the North Fayette Health + Wellness Pavilion.
  • North Fayette will become AHN's sixth Health + Wellness Pavilion, joining others serving the communities of Wexford, Bethel Park, Peters Township and Erie's east and west sides.

Carestream Explores Potential of X-ray Imaging for Earlier Detection and Treatment of Idiopathic Pulmonary Fibrosis

Retrieved on: 
Wednesday, March 1, 2023
Cardiology, Biotechnology, Other Health, Health, General Health, Radiology, Biometrics, Medical Devices, Research, Hospitals, Science, Vital capacity, Pulmonology, CTS, Pathology, Diagnosis, Project, Artificial intelligence, Biomarker, Algorithm, Standard of care, Patient, CT, APF, Cough, AI, Pulmonary fibrosis, Innovation, American Lung Association, Idiopathic pulmonary fibrosis, IPF, Open source, Blood, FVC, ALA, X-ray, Intelligence Advanced Research Projects Activity, EU, OPUS, Medical imaging, Carestream Health

Carestream Health is funding and participating in an innovative pilot with the Open Source Imaging Consortium (OSIC) that could lead to radiographs providing an early window into manifestations of idiopathic pulmonary fibrosis (IPF) that are currently undetected, thus leading to earlier diagnosis and treatment.

Key Points: 
  • Carestream Health is funding and participating in an innovative pilot with the Open Source Imaging Consortium (OSIC) that could lead to radiographs providing an early window into manifestations of idiopathic pulmonary fibrosis (IPF) that are currently undetected, thus leading to earlier diagnosis and treatment.
  • “If this pilot uncovers markers that are currently undetected in X-rays, it could lead to earlier detection and treatment of patients with IPF.
  • Project OPUS is a collaborative effort between OSIC, Carestream, patientMpower, the American Lung Association (ALA) , European Pulmonary Fibrosis Federation (EU-IPFF) and Action for Pulmonary Fibrosis (APF) .
  • “Project OPUS is just one area where Carestream is exploring the potential of X-ray imaging to play an expanded role in diagnosis and care management of various pathologies,” said Dr. Bogoni.